Literature DB >> 13129639

Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey.

Dirk De Ruysscher1, Ben Slotman.   

Abstract

A survey was performed on the radiotherapy practice of malignant pleural mesothelioma in The Netherlands and Belgium in 2002. Thirty-eight out of 47 centres (81%) responded. Prophylactic radiotherapy to intervention sites is given by 32/38 (84%) centres, with all centres offering palliative radiation. For both prophylactic and palliative indications, all centres use hypo-fractionated schedules. The present study shows that in the radiotherapy community in The Netherlands and in Belgium, a de facto consensus exists that both prophylactic and symptomatic radiotherapy to intervention sites of malignant pleural mesothelioma are effective and that hypo-fractionated schedules should be used.

Entities:  

Mesh:

Year:  2003        PMID: 13129639     DOI: 10.1016/s0167-8140(03)00229-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

Review 1.  What is the role of radiotherapy in malignant pleural mesothelioma?

Authors:  Allan Price
Journal:  Oncologist       Date:  2011-02-23

Review 2.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

3.  Radiotherapy applications of patients with malignant mesothelioma: A single center experience.

Authors:  Muge Akmansu; Ozge Petek Erpolat; Fatih Goksel; Evrim Tunc; Can Ozturk
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-09

4.  Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases.

Authors:  Amelia O Clive; Paula Wilson; Hazel Taylor; Anna J Morley; Emma de Winton; Niki Panakis; Najib Rahman; Justin Pepperell; Timothy Howell; Timothy J P Batchelor; Nikki Jordan; Y C Gary Lee; Lee Dobson; Nick A Maskell
Journal:  BMJ Open       Date:  2015-01-09       Impact factor: 2.692

5.  Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.

Authors:  Amelia O Clive; Hazel Taylor; Lee Dobson; Paula Wilson; Emma de Winton; Niki Panakis; Justin Pepperell; Timothy Howell; Samuel A Stewart; Erika Penz; Nikki Jordan; Anna J Morley; Natalie Zahan-Evans; Sarah Smith; Timothy J P Batchelor; Adrian Marchbank; Lesley Bishop; Alina A Ionescu; Mike Bayne; Samantha Cooper; Anthony Kerry; Peter Jenkins; Elizabeth Toy; Vallipuram Vigneswaran; James Gildersleve; Merina Ahmed; Fiona McDonald; Mick Button; Conrad Lewanski; Charles Comins; Muthukumar Dakshinamoorthy; Y C Gary Lee; Najib M Rahman; Nick A Maskell
Journal:  Lancet Oncol       Date:  2016-06-23       Impact factor: 41.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.